Lusitropy

Lusitropy is myocardial relaxation. The increase in cytosolic calcium of cardiomyocytes via increased uptake leads to increased myocardial contractility (positive inotropic effect), but the myocardial relaxation, or lusitropy, decreases. This should not be confused, however, with catecholamine-induced calcium uptake into the sarcoplasmic reticulum, which increases lusitropy.

Positive

Increased catecholamine levels promote positive lusitropy, enabling the heart to relax more rapidly. This effect is mediated by the phosphorylation of phospholamban and troponin I via a cAMP-dependent pathway. Catecholamine-induced calcium influx into the sarcoplasmic reticulum increases both inotropy and lusitropy. In other words, a quicker reduction in cytosolic calcium levels (because the calcium enters the sarcoplasmic reticulum) causes an increased rate of relaxation (+ lusitropy), however that also enables a greater degree of calcium efflux, back into the cytosol, when the next action potential arrives, thereby increasing inotropy as well. Do not confuse this calcium mechanism with calcium uptake from the extracellular fluid. Increased calcium uptake from the extracellular fluid into the cytoplasm decreases lusitropy in the absence of catecholamine stimulation, but increased calcium uptake into the sarcoplasmic reticulum, via catecholamines, increases lusitropy and inotropy.

Negative

Relaxation of the heart is negatively impacted by the following factors:

1) Calcium overload - too much intracellular calcium
2) Reduced rate of calcium removal from myocyte through pumps - if calcium is not removed from the cell quickly enough.

a) Plasma membrane Calcium ATPase (Ca ATPase) - this primary active transporter pumps calcium out of the myocyte between beats
b) Sodium-Calcium (Na/Ca) exchanger - this secondary active transporter pumps calcium out of cell between beats

3) Impaired Sarco-Endoplasmic Reticulum Calcium ATPase (SERCA) - this primary active transporter pumps calcium from the cytoplasm of the myocyte into its sarco-endoplasmic reticulum.

Therefore, any impairment of the transporters in (2) and (3) would have a negative lusitropic effect.

In contrast, enhancement of these same transporters would have a positive inotropic effect

References

  • https://www.hu.liu.se/lakarprogr/t2/t2-filer/1.59634/Lusitropy.pdf
  • http://ceaccp.oxfordjournals.org/content/7/3/85.full.pdf


fr:Lusitrope
This article was sourced from Creative Commons Attribution-ShareAlike License; additional terms may apply. World Heritage Encyclopedia content is assembled from numerous content providers, Open Access Publishing, and in compliance with The Fair Access to Science and Technology Research Act (FASTR), Wikimedia Foundation, Inc., Public Library of Science, The Encyclopedia of Life, Open Book Publishers (OBP), PubMed, U.S. National Library of Medicine, National Center for Biotechnology Information, U.S. National Library of Medicine, National Institutes of Health (NIH), U.S. Department of Health & Human Services, and USA.gov, which sources content from all federal, state, local, tribal, and territorial government publication portals (.gov, .mil, .edu). Funding for USA.gov and content contributors is made possible from the U.S. Congress, E-Government Act of 2002.
 
Crowd sourced content that is contributed to World Heritage Encyclopedia is peer reviewed and edited by our editorial staff to ensure quality scholarly research articles.
 
By using this site, you agree to the Terms of Use and Privacy Policy. World Heritage Encyclopedia™ is a registered trademark of the World Public Library Association, a non-profit organization.